Dyne Therapeutics, Inc. DYN Return on equity

Return on equity at other companies

Sarepta Therapeutics, Inc.SRPT

-9.3%+2,662pp

Ionis PharmaceuticalsIONS

-105.5%+336pp

Arrowhead ResearchARWR

-46.4%+341pp

Wave Life SciencesWVE

-68.3%—

Solid Biosciences Inc.SLDB

-65.5%-2.5pp

Edgewise Therapeutics, Inc.EWTX

-38.1%+13.4pp

FAQ

What is Dyne Therapeutics, Inc.'s return on equity?

Dyne Therapeutics, Inc. (DYN) reported return on equity of -58.9% in Q1 2026.

How has Dyne Therapeutics, Inc.'s return on equity changed year-over-year?

Dyne Therapeutics, Inc.'s return on equity increased by 8.0% year-over-year, from -64% to -58.9%.

What is the long-term trend for Dyne Therapeutics, Inc.'s return on equity?

Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s return on equity has grown at a 10.8% compound annual growth rate (CAGR), from -33.4% to -55.7%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.